May 18, 2020 – FORTUNE – ARTICLE BY MARIA ASPAN – Allergan’s “medical aesthetics” products helped persuade AbbVie to buy the company. But what if the devices driving profit are also endangering women’s health?
“The breast implants that are on the market right now all have issues,” says Madris Tomes, a former FDA manager who tracks reported medical device failures at her Device Events firm. “I wouldn’t recommend them to anyone that I care about.”
